Get it on Google Play

Syneron Medical (ELOS) Receives FDA Approval for Plus

July 2, 2012 4:35 PM EDT
Syneron Medical Ltd. (NASDAQ: ELOS) has received United States Food and Drug Administration (FDA) clearance for elos Plus™, a next generation multi-platform system featuring the Company's proprietary elos technology. The FDA clearance for elos Plus™ follows on the recent international launch in Europe and Asia.

The new elos Plus™ leverages the Company's proprietary elos® technology of optical energy and bi-polar radiofrequency to provide safe and efficacious treatments.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories